Hayat Pharmaceutical Industries Co. PLC (ASE:HPIC)
3.120
-0.020 (-0.64%)
At close: Oct 28, 2026
ASE:HPIC Revenue
Hayat Pharmaceutical Industries Co. had revenue of 3.11M JOD in the quarter ending September 30, 2026, a decrease of -45.54%. This brings the company's total for the last twelve months to 14.79M, down -16.34% year-over-year. In the year 2025, Hayat Pharmaceutical Industries Co. had annual revenue of 17.11M with 2.39% growth. That makes Hayat Pharmaceutical Industries Co. the 33,569th largest company in the world by revenue and 64th in Jordan.
Revenue (ttm)
14.79M
Revenue Growth
-16.34%
P/S Ratio
2.00
Revenue / Employee
60.14K
Employees
246
Market Cap
29.64M
Revenue by Geography
- Export 9.44M 55.2%
- Jordan 7.67M 44.8%
Fiscal year ended Dec 31, 2025 See the full ASE:HPIC breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 17.11M | 399.74K | 2.39% |
| Dec 31, 2024 | 16.71M | 903.56K | 5.72% |
| Dec 31, 2023 | 15.81M | -1.30M | -7.61% |
| Dec 31, 2022 | 17.11M | 522.31K | 3.15% |
| Dec 31, 2021 | 16.58M | 3.35K | 0.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.